Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biliary Problems in People with HIV Disease.

Walden1

  • 1Division of Gastroenterology, Washington University School of Medicine, One Barnes-Jewish Hospital Plaza, Box 8124, St. Louis, MO 63110.

Current Treatment Options in Gastroenterology
|November 30, 2000
PubMed
Summary

Gallstones are a common cause of acute cholecystitis in HIV patients. While cholecystectomy can relieve pain, HIV cholangiopathy may cause persistent symptoms, sometimes requiring endoscopic retrograde cholangiopancreatography (ERCP).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Role of quasideuteron absorption in the 6Li( pi +, pp) reaction at T pi +=100, 165 MeV.

Physical review. C, Nuclear physics·1996
Same author

Final-state interactions and CP violation in KL--> pi + pi - e+e-

Physical review. D, Particles and fields·1996
Same author

Multiple scattering of classical waves in systems with liquidlike correlations: Formulation as a liquid-state theory.

Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics·1995
Same author

6Li( pi +, pp)4Heg.s. reaction at 100 and 165 MeV incident pion energies.

Physical review. C, Nuclear physics·1995
Same author

Laser with injected squeezed vacuum: Phase diffusion and intensity fluctuations.

Physical review. A, Atomic, molecular, and optical physics·1994
Same author

Exclusive pion production from few nucleon systems in the region of the Delta 1232 resonance.

Physical review. C, Nuclear physics·1994

Area of Science:

  • Gastroenterology
  • Infectious Diseases
  • Hepatology

Background:

  • Antiretroviral therapy has made biliary problems in HIV patients similar to those in non-immunosuppressed individuals, primarily gallstone-related.
  • Acute cholecystitis in HIV patients presents diagnostic challenges, with potential complications like HIV cholangiopathy.

Purpose of the Study:

  • To outline diagnostic and management strategies for acute cholecystitis in HIV-infected patients.
  • To differentiate gallstone-induced cholecystitis from HIV cholangiopathy and guide treatment decisions.

Main Methods:

  • Review of clinical presentations and diagnostic approaches for biliary tract disease in HIV patients.
  • Discussion of the role of abdominal ultrasound and endoscopic retrograde cholangiopancreatography (ERCP) in diagnosis and management.

Related Experiment Videos

  • Consideration of perioperative risks and outcomes in HIV-infected patients undergoing biliary procedures.
  • Main Results:

    • Gallstones are the predominant cause of cholecystitis in HIV patients on antiretroviral therapy.
    • HIV cholangiopathy, a complication of severe immunosuppression, affects about half of patients and can lead to persistent symptoms post-cholecystectomy.
    • ERCP with sphincterotomy is effective for symptomatic papillary stenosis but less beneficial for asymptomatic elevated liver enzymes in HIV patients.

    Conclusions:

    • Management of acute cholecystitis in HIV patients requires careful consideration of gallstone disease versus HIV cholangiopathy.
    • While cholecystectomy can be effective, the potential for concurrent HIV cholangiopathy necessitates patient counseling regarding possible ongoing symptoms and need for ERCP.
    • ERCP is recommended for symptomatic papillary stenosis but should be used judiciously for asymptomatic liver enzyme elevations in HIV patients due to limited benefits and risks.